<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <title>Extracted Document</title>
    <style>
        body { font-family: Arial, sans-serif; max-width: 900px; margin: 0 auto; padding: 20px; }
        h1, h2, h3 { color: #333; }
        .page { margin-bottom: 50px; border-bottom: 2px solid #ccc; padding-bottom: 30px; }
        .title { font-size: 1.3em; font-weight: bold; margin: 20px 0; }
        .text { margin: 15px 0; line-height: 1.6; }
        .figure { margin: 20px 0; text-align: center; }
        .figure img { max-width: 100%; height: auto; border: 1px solid #ddd; }
        .figure-caption { font-style: italic; color: #666; margin-top: 10px; }
        .metadata { background: #f5f5f5; padding: 15px; margin-top: 30px; }
    </style>
</head>
<body>

<h1>Extracted Document</h1>
<p><strong>Source:</strong> data/clinical_files/CDC Influenza vaccines.pdf</p>
<p><strong>Total Pages:</strong> 2</p>
<hr>
<div class="page">
<h2>Page 1</h2>
<div class="title">Flu zone Quad rival ent (San of i Pasteur) 0.5-mL PFS†† ≥6 mos†† 15 µg/0.5 mL IM 0.5-mL SDV†† ≥6 mos†† 15 µg/0.5 mL IM 5 0-mL MDV†† ≥6 mos†† 7 5 µg/0 25 mL IM 25 ¶ ¶ ¶</div>
<div class="figure">
<img src="figures/figure_p1_det_0_003.png" alt="[FIGURE 2 - See figure_p1_det_0_003.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 2 - See figure_p1_det_0_003.png]</div>
</div>
<div class="title">( ) FluLaval Quad rival ent 0 5 mL PFS ≥6 mos 15 µg/0 5 mL</div>
<div class="title">(Seqirus)</div>
<div class="text">Afluria Quad rival ent 0.5-mL PFS§</div>
<div class="text">nfluenza (Flu)</div>
<div class="title"></div>
<div class="title"></div>
<div class="figure">
<img src="figures/figure_p1_det_0_011.png" alt="[FIGURE 10 - See figure_p1_det_0_011.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 10 - See figure_p1_det_0_011.png]</div>
</div>
</div>
<div class="page">
<h2>Page 2</h2>
<div class="figure">
<img src="figures/figure_p2_det_1_000.png" alt="[FIGURE 1 - See figure_p2_det_1_000.png]" style="max-width: 800px;">
<div class="figure-caption">[FIGURE 1 - See figure_p2_det_1_000.png]</div>
</div>
<div class="text">Flu zone Quad rival ent is approved 0 25 L fill d i</div>
<div class="text">Guidelines for Immunization a</div>
<div class="text">IM-administered influenza vaccines should be administered by needle and syringe only, with the exception of the MDV presentation of Afluria Quad rival ent, which may alternatively be given by the PharmaJet Strat is jet injector for persons age ¶</div>
<div class="text">The approved dose volume for Afluria Quad rival ent is 0.25 mL for children aged 6 through 35 months and 0.5 mL for persons aged ≥3 years. However, 0.25-mL pre filled syringes are no longer available. For children aged 6 through 35 §</div>
<div class="text">that any influenza vaccine (egg based or non egg based) that is otherwise appropriate for the recipient sage and health status can be used (see Persons with a History of Egg Allergy).</div>
<div class="text">Although a history of severe allergic reaction (e.g., anaphylaxis) to egg is a labeled contra indication to the use of egg based †</div>
<div class="text">Flublok Quad rival ent (San of i Pasteur) 0.5 mL PFS ≥18 yrs 45 µg/0.5 mL IM LAIV4 (egg based vaccine ) Flu mist Quad rival ent (Astr a zen eca) 0.2-mL pre filled single use intr a nasal sprayer 2 through 49 yrs 10 fluorescent focus units 0 2 mL NAS Abbreviations: ACIP = Advisory Committee on Immunization Practices; HA = hemagglutinin; IIV4 = in activated influenza vaccine, quad rival ent; IM = intramuscular; LAIV4 = live attenuated influenza vaccine, quad rival ent; MDV = multi dose vial; PFS = pre filled syringe; RIV4 = recombinant influenza vaccine, quad rival ent; SDV = single dose vial. * Manufacturer package inserts and updated CDC and ACIP guidance should be consulted for additional information concerning, but not limited to, indications, contra indications, warnings, and precautions. Package inserts for U.S.-licensed vaccines are available at https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states . † 6 5 7 5 </div>
<div class="title">Q (Seqirus) y µg RIV4 (recombinant HA vaccine)</div>
</div>
<div class="metadata">
<h3>Extraction Metadata</h3>
<p>Text blocks: 13</p>
<p>Figures/Tables: 3</p>
</div>

</body>
</html>
